VYGR
Voyager Therapeutics·NASDAQ
--
--(--)
--
--(--)
VYGR fundamentals
Voyager Therapeutics (VYGR) released its earnings on Nov 10, 2025: revenue was 13.37M (YoY -45.73%), beat estimates; EPS was -0.47 (YoY -193.75%), beat estimates.
Revenue / YoY
13.37M
-45.73%
EPS / YoY
-0.47
-193.75%
Report date
Nov 10, 2025
EPS
Actual | -0.66 | -0.23 | 2.27 | -0.43 | -0.58 | -0.8 | -0.67 | 0.15 | -0.56 | -0.5 | 0.45 | -0.61 | 2.94 | -0.51 | -0.59 | 1.25 | -0.2 | -0.18 | -0.16 | -0.59 | -0.53 | -0.57 | -0.47 | ||||||||||
Forecast | -0.7893 | -0.7164 | -0.1883 | -0.56 | -0.6437 | -0.7279 | -0.7475 | -0.6238 | -0.3709 | -0.4771 | -0.3171 | -0.5457 | -0.325 | -0.5688 | -0.5811 | -0.289 | -0.4393 | -0.4091 | -0.4448 | -0.3667 | -0.4487 | -0.5256 | -0.5209 | ||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +16.38% | +67.90% | +1305.52% | +23.21% | +9.90% | -9.91% | +10.37% | +124.05% | -50.98% | -4.80% | +241.91% | -11.78% | +1004.62% | +10.34% | -1.53% | +532.53% | +54.47% | +56.00% | +64.03% | -60.89% | -18.12% | -8.45% | +9.77% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 18.07M | 28.68M | 117.84M | 6.54M | 6.50M | 1.36M | 1.48M | 28.07M | 658.00K | 712.00K | 41.09M | -1.55M | 150.48M | 4.85M | 4.61M | 90.06M | 19.50M | 29.58M | 24.63M | 6.28M | 6.47M | 5.20M | 13.37M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 13.55M | 16.52M | 15.05M | 16.59M | 7.55M | 4.18M | 2.14M | 4.30M | 12.71M | 7.03M | 9.42M | 3.73M | 10.04M | 1.60M | 2.91M | 20.63M | 9.48M | 9.51M | 11.70M | 16.58M | 13.91M | 9.91M | 7.86M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +33.37% | +73.56% | +682.84% | -60.59% | -13.85% | -67.50% | -30.84% | +553.41% | -94.82% | -89.87% | +336.34% | -141.54% | +1398.80% | +202.99% | +58.69% | +336.50% | +105.70% | +210.88% | +110.46% | -62.14% | -53.45% | -47.51% | +70.00% |
Earnings Call
You can ask Aime
Did Voyager Therapeutics beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Voyager Therapeutics year over year?What is Voyager Therapeutics's gross profit margin?What were the key takeaways from Voyager Therapeutics's earnings call?What guidance did Voyager Therapeutics's management provide for the next earnings period?What does Voyager Therapeutics do and what are its main business segments?What were the key takeaways from Voyager Therapeutics’s earnings call?What factors drove the changes in Voyager Therapeutics's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
